NCT00838214 Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis Status COMPLETED Phase PHASE2/PHASE3
NCT00828061 A Study of the Effects of Single Dose Corticosteroids on Response to Allergens Status COMPLETED Phase PHASE1
NCT00825149 A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00822120 S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00815919 Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease Status COMPLETED Phase PHASE2
NCT00812123 Calcineurin Free Immunosuppression in Renal Transplant Recipients Status COMPLETED Phase PHASE4
NCT00811031 Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) Status WITHDRAWN Phase PHASE2
NCT00809341 R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00799539 A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients Status NO_LONGER_AVAILABLE Phase N/A
NCT00792948 Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00789997 TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial Status COMPLETED Phase PHASE2/PHASE3
NCT00787527 SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00774852 Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis Status COMPLETED Phase PHASE2
NCT00772668 Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL Status TERMINATED Phase NA
NCT00770848 AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00770224 S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00764907 Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia Status UNKNOWN Phase PHASE3
NCT00744497 Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT00736450 Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Status TERMINATED Phase EARLY_PHASE1
NCT00734149 Bortezomib With Melphalan and Prednisone for Multiple Myeloma Status COMPLETED Phase PHASE2